TRMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. TRMD’s chart remains in a bullish uptrend (SMA_5 > SMA_20 > SMA_200), but momentum is getting stretched (RSI_6 ~75) and price is sitting just below near-term resistance (R1 ~24.51) after a small post-market dip. With no Intellectia buy signals today and the latest quarter showing sharp YoY profit/EPS deterioration, the risk/reward for an impatient entry at current levels is unfavorable. Best stance: hold/avoid new buys until a pullback closer to ~23.33 support or a clean breakout above ~24.51–25.24.
Trend: Bullish structure with stacked moving averages (SMA_5 > SMA_20 > SMA_200), indicating the broader trend is up. Momentum: MACD histogram is positive (0.19) but contracting, suggesting upside momentum is weakening. RSI_6 is ~75.5 (stretched/near-overbought), implying near-term pullback risk. Levels: Pivot support ~23.335 (first key support zone), deeper support ~22.158. Resistance is near ~24.512, then ~25.238. With price ~24.02 post-market, it’s closer to resistance than support, which is a poor entry for an impatient buyer.
Intellectia Proprietary Trading Signals:
Technical uptrend remains intact (bullish moving-average stack). Options open-interest skew is bullish (PCR OI 0.57), indicating constructive positioning. One notable analyst upgrade (Fearnley to Buy) provides some external support.
and MACD momentum is fading (positive but contracting), with price sitting below resistance (~24.51), increasing pullback risk. No supportive news/catalysts in the last week. Statistical pattern outlook provided is slightly negative for the next week/month. Recent fundamentals (2025/Q
show meaningful YoY deterioration in revenue and especially earnings.
Latest reported quarter: 2025/Q3. Revenue fell to 342.6M (-7.93% YoY). Net income dropped to 77.6M (-40.54% YoY). EPS declined to 0.77 (-44.20% YoY). Gross margin decreased to 53.59 (-7.98% YoY). Overall: growth trend is negative YoY with sharper pressure on profitability than sales, which weakens the fundamental case for chasing the stock near resistance.
Recent trend: limited coverage changes in the provided data; the key update is a 2025-11-13 upgrade by Fearnley (Fredrik Dybwad) to Buy from Hold with a DKK 172 price target. Wall Street-style pros: external validation via upgrade and an uptrending chart. Cons: earnings power weakened materially in the latest quarter, and there’s no broad, multi-analyst upward revision trend shown here. Trading influence: hedge funds and insiders are neutral; no notable congress trading data available.
